For 5-amino-1MQ specifically: Preclinical studies have not prominently described heart rate elevation as a dominant signal The mechanism (NNMT inhibition, NAD+ preservation) does not have the same direct cardiac implications as nuclear receptor agonism Human cardiovascular data at clinically relevant exposures are limited For physicians, the current evidence base does not support a major cardiovascular safety flag, but the limited human dataset means confident statements are premature
To put that in perspective, the best semaglutide clinical trials showed approximately 15-17% weight reduction, and tirzepatide results peaked around 20-22%
AOD9604 is a well-characterized peptide fragment studied for its role in cellular signaling pathways and metabolic research models
Afterwards, seek maintenance injections every two to four weeks, depending on your medical history
50 ml vial
References For Further Reading (1) F Gorouhi and H I Maibach (2009) Role of topical peptides in preventing or treating aged skin -International Journal of Cosmetic Science, 2009 Oct, Volume 31 (Issue 5), Pages 327-45